Mizuho Securities Remains Sidelined Following Endo Int'l's (ENDP) Mixed 4Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Ovintiv adds 41,000 acres in Permian and Montney deals
- Russia says it could strike UK military targets in response to Kyiv's use of British missiles
Piper Jaffray Remains Bullish on Endo Int'l (ENDP) Following an In-Line 4Q - PT to $81
March 1, 2016 9:04 AM ESTPiper Jaffray maintained an Overweight rating on Endo International plc (NASDAQ: ENDP), and cut the price target to $81.00 (from $83.00), following the company's relatively in-line 4Q earnings results. Endo reported 4Q15 non-GAAP EPS of $1.36 on revenues of $1.1B. Sales of Xiaflex in 4Q15 were $50M, up 26% versus 3Q15 sales of $40M, with ENDP citing... More
Leerink Partners Cuts Price Target on Endo Int'l (ENDP) Following 4Q Earnings Report
March 1, 2016 7:50 AM ESTLeerink Partners maintained an Outperform rating on Endo International plc (NASDAQ: ENDP), and cut the price target to $51.00 (from $64.00), following the company's 4Q earnings report. ENDP generics were unfavorably impacted by increased pricing pressure in pain and commodity products within legacy Qualitest, an... More
Notable 52-Week Highs and Lows 2/29: (JCP) (GSS) (DPZ) High; (ENDP) (IPI) (FSS) Low
February 29, 2016 3:24 PM EST52-Week High:J.C. Penney (NYSE: JCP) $10.18. J.C. Penney adding to gains from last Friday after it reported Q4 EPS of $0.39 with revenue of $4 billion, versus consensus estimates calling for EPS of $0.23 and revenue of $4 billion. Comparable store sales grew 4.1% for the fourth quarter and 4.5% for the full year.
Golden Star... More
Unusual 11 Mid-Day Movers 2/29: (ATNY) (FDML) (ALDX) Higher; (IPI) (UNFI) (FSS) Lower
February 29, 2016 12:56 PM ESTAPI Technologies Corp. (Nasdaq: ATNY) 93.1% HIGHER; announced a definitive agreement providing for the Company to be acquired by an affiliate of private equity firm J. F. Lehman & Company ("JFLCO"), which specializes in the aerospace, maritime and defense industries.
Intrepid Potash (NYSE: IPI) 56.8% LOWER; reported Q4 EPS of ($0.26), $0.15 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $42.8 million versus the consensus estimate of $61.67 million.
Federal-Mogul Holdings Corporation (Nasdaq:... More
S&P 500 slides below closely watched threshold
February 29, 2016 7:33 AM ESTBy Noel Randewich
(Reuters) - Wall Street ended lower on Monday, falling out of lockstep with oil prices as energy and healthcare shares lost ground.
U.S. indexes gave up early gains despite a 3 percent rally in U.S. oil prices. Stocks and oil have been strongly correlated in recent months as crude prices tanked to decade lows, and their movements in opposite directions during the session was notable to investors.
Following gains last week, technical trading dominated the action as the S&P 500 fell below its 50-day moving average, a sign seen as bad for... More
Endo Int'l (ENDP) Tops Q4 EPS by 9c; Guides FY16 EPS
February 29, 2016 6:34 AM ESTEndo Int'l (NASDAQ: ENDP) reported Q4 EPS of $1.36, $0.09 better than the analyst estimate of $1.27. Revenue for the quarter came in at $1.07 billion versus the consensus estimate of $1.07 billion.
GUIDANCE:
Endo Int'l sees FY2016 EPS of $5.85-$6.20, versus the consensus of... More
